Spots Global Cancer Trial Database for neuroendocrine neoplasms
Every month we try and update this database with for neuroendocrine neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) | NCT04086485 | Gastroenteropan... Neuroendocrine ... Neuroendocrine ... | Lu-177-DOTATATE Olaparib Ga dotatate sca... FDG-PET scannin... Amino Acid infu... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers | NCT05882058 | Small Cell Lung... Neuroendocrine ... | BI 764532, form... BI 764532, form... | 18 Years - | Boehringer Ingelheim | |
| A Study to Test How Well Different Doses of BI 764532 in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 | NCT05879978 | Small Cell Lung... Neuroendocrine ... | BI 764532 Ezabenlimab | 18 Years - | Boehringer Ingelheim | |
| Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery | NCT02315625 | Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoma, Neur... Neuroendocrine ... | Sunitinib Everolimus | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers | NCT05882058 | Small Cell Lung... Neuroendocrine ... | BI 764532, form... BI 764532, form... | 18 Years - | Boehringer Ingelheim | |
| Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms | NCT05871320 | Neuroendocrine ... | [99mTc]Tc-TECAN... | 21 Years - | Jagiellonian University | |
| DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers | NCT06132113 | Neuroendocrine ... | BI 764532 Carboplatin Etoposide Cisplatin | 18 Years - | Boehringer Ingelheim | |
| Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery | NCT02315625 | Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoma, Neur... Neuroendocrine ... | Sunitinib Everolimus | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk | NCT05268783 | Quality of Life | EORTC QLQ-C30 EORTC QLQ-GI.NE... Satisfaction su... | 18 Years - | University Hospital, Antwerp | |
| A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer | NCT05963867 | Small Cell Lung... Neuroendocrine ... | BI 764532 [89Zr]Zr-BI 764... | 18 Years - | Boehringer Ingelheim |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
